{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:23:08Z","timestamp":1793013788650,"version":"4.5.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi251415-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Influenza and tetanus-diphtheria-acellular pertussis (Tdap) vaccinations during pregnancy offer protection to infants from infections. However, evidence about their effectiveness against hospitalization and emergency department (ED) visits associated with influenza and pertussis remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251415-2\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate the association of maternal influenza and Tdap vaccinations with influenza- and pertussis-related hospitalizations and ED visits in infants younger than 6 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251415-3\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This population-based cohort study used the health care utilization databases from the Lombardy region of Italy. Pregnant individuals who received the influenza and Tdap vaccine among all live-birth pregnancies in 2018 to 2022 were included. Each vaccinated mother was matched with a nonvaccinated counterpart based on month and year of delivery, gestational age at birth, and pregnancy multiplicity. Analyses were performed from April 2024 to February 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251415-4\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Exposures of interest were influenza and Tdap vaccinations during pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251415-5\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcomes were infant hospitalizations or ED visits due to influenza and pertussis. Cox regression models were fitted to estimate the hazard ratio (HR) of each outcome associated with the corresponding maternal vaccine. Vaccine effectiveness (VE) was calculated as VE\u2009=\u2009(1\u2009\u2212\u2009HR)\u2009\u00d7\u2009100%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251415-6\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study included 53\u202f448 pregnant individuals who received the Tdap vaccine and 5347 who received  influenza vaccine. The maternal vaccination coverage (ie, proportion of vaccinated pregnant individuals among those eligible) was 5359 (6.4%) for influenza and 70\u202f119 (41.0%) for Tdap, respectively. Infants born to mothers who received the influenza and Tdap vaccine had a lower risk of hospitalization or ED visit for influenza (VE, 69.7%; 95% CI, 8.7%-90.0%) and pertussis (VE, 88.6%; 95% CI, 11.5%-98.5%), respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251415-7\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This study found that maternal influenza and Tdap vaccinations were associated with reduced influenza- and pertussis-related hospitalization or ED visits in infants younger than 6 months. Given the low vaccination coverage, it is crucial to implement maternal vaccination campaigns to enhance infant health outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.53179","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:00:45Z","timestamp":1767888045000},"page":"e2553179","source":"Crossref","is-referenced-by-count":5,"title":["Maternal Vaccine Receipt and Infant Hospital and Emergency Visits for Influenza and Pertussis"],"prefix":"10.1001","volume":"9","author":[{"given":"Gabriella","family":"Morabito","sequence":"first","affiliation":[{"name":"National Centre for Healthcare Research and Pharmacoepidemiology, at the University of Milano-Bicocca Milan, Italy"},{"name":"Laboratory of Healthcare Research and Pharmacoepidemiology, Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Corrao","sequence":"additional","affiliation":[{"name":"University of Milano-Bicocca (Emeritus Professor), Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Giaquinto","sequence":"additional","affiliation":[{"name":"Department for Women\u2019s and Children\u2019s Health, University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cantarutti","sequence":"additional","affiliation":[{"name":"National Centre for Healthcare Research and Pharmacoepidemiology, at the University of Milano-Bicocca Milan, Italy"},{"name":"Laboratory of Healthcare Research and Pharmacoepidemiology, Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Di Chiara","sequence":"additional","affiliation":[{"name":"Department for Women\u2019s and Children\u2019s Health, University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"3","key":"zoi251415r1","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1097\/INF.0000000000001440","article-title":"Incidence and burden of pertussis among infants less than 1 year of age.","volume":"36","author":"Masseria","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"zoi251415r2","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.1016\/S2214-109X(19)30545-5","article-title":"Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study.","volume":"8","author":"Wang","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"2","key":"zoi251415r3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.pcl.2022.11.004","article-title":"Maternal vaccination and vaccine hesitancy.","volume":"70","author":"Rand","year":"2023","journal-title":"Pediatr Clin North Am"},{"issue":"17","key":"zoi251415r4","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1056\/NEJMc0912599","article-title":"Influenza immunization in pregnancy-antibody responses in mothers and infants.","volume":"362","author":"Steinhoff","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi251415r5","doi-asserted-by":"publisher","first-page":"334.e1","DOI":"10.1016\/j.ajog.2010.11.024","article-title":"Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels.","volume":"204","author":"Gall","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"52","key":"zoi251415r6","doi-asserted-by":"publisher","first-page":"8405","DOI":"10.1016\/j.vaccine.2020.07.014","article-title":"Effectiveness of influenza vaccination during pregnancy to prevent severe infection in children under 6 months of age, Spain, 2017-2019.","volume":"38","author":"Mazagatos","year":"2020","journal-title":"Vaccine"},{"issue":"6","key":"zoi251415r7","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/infdis\/jix629","article-title":"Protective effect of maternal influenza vaccination on influenza in their infants: a prospective cohort study.","volume":"217","author":"Ohfuji","year":"2018","journal-title":"J Infect Dis"},{"issue":"7","key":"zoi251415r8","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.vaccine.2019.12.056","article-title":"The effectiveness of influenza vaccination in pregnancy in relation to child health outcomes: systematic review and meta-analysis.","volume":"38","author":"Jarvis","year":"2020","journal-title":"Vaccine"},{"issue":"3","key":"zoi251415r9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-051076","article-title":"Maternal vaccination and infant influenza and pertussis.","volume":"148","author":"Rowe","year":"2021","journal-title":"Pediatrics"},{"issue":"2","key":"zoi251415r10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamapediatrics.2023.5639","article-title":"Maternal vaccine effectiveness against influenza-associated hospitalizations and emergency department visits in infants.","volume":"178","author":"Sahni","year":"2024","journal-title":"JAMA Pediatr"},{"issue":"1","key":"zoi251415r11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12879-020-4824-3","article-title":"Safety and effectiveness of acellular pertussis vaccination during pregnancy: a systematic review.","volume":"20","author":"Vygen-Bonnet","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"10","key":"zoi251415r13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/vaccines9101107","article-title":"Flu and Tdap maternal immunization hesitancy in times of COVID-19: an Italian survey on multiethnic sample.","volume":"9","author":"Cavaliere","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"zoi251415r14","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.1038\/s41598-022-11308-3","article-title":"Trends of influenza vaccination coverage in pregnant women: a ten-year analysis from a French healthcare database.","volume":"12","author":"Corbeau","year":"2022","journal-title":"Sci Rep"},{"issue":"23","key":"zoi251415r15","doi-asserted-by":"publisher","first-page":"12621","DOI":"10.3390\/ijerph182312621","article-title":"Use of antibiotic treatment in pregnancy and the risk of several neonatal outcomes: a population-based study.","volume":"18","author":"Cantarutti","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"zoi251415r16","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jad.2023.07.066","article-title":"Antidepressant continuation and adherence in pregnancy, and risk of antenatal hospitalization for unipolar major depressive and\/or anxiety disorders.","volume":"339","author":"Lupattelli","year":"2023","journal-title":"J Affect Disord"},{"issue":"9596","key":"zoi251415r18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"25","key":"zoi251415r19","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"6","key":"zoi251415r20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks.","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"zoi251415r21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/biomet\/80.3.557","article-title":"Checking the Cox Model with cumulative sums of martingale-based residuals.","volume":"80","author":"Lin","year":"1993","journal-title":"Biometrika"},{"issue":"12","key":"zoi251415r22","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1086\/657309","article-title":"Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants.","volume":"51","author":"Benowitz","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"45","key":"zoi251415r23","doi-asserted-by":"publisher","first-page":"20959","DOI":"10.2807\/1560-7917.ES2014.19.45.20959","article-title":"Effectiveness of seasonal influenza vaccination during pregnancy in preventing influenza infection in infants, England, 2013\/14.","volume":"19","author":"Dabrera","year":"2014","journal-title":"Euro Surveill"},{"issue":"6","key":"zoi251415r24","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-2360","article-title":"Influenza in infants born to women vaccinated during pregnancy.","volume":"137","author":"Shakib","year":"2016","journal-title":"Pediatrics"},{"issue":"2","key":"zoi251415r25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.amepre.2018.04.013","article-title":"Effectiveness of Prenatal tetanus, diphtheria, acellular pertussis vaccination in the prevention of infant pertussis in the US.","volume":"55","author":"Becker-Dreps","year":"2018","journal-title":"Am J Prev Med"},{"issue":"14","key":"zoi251415r26","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.vaccine.2018.02.047","article-title":"Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: the NSW Public Health Network case-control study.","volume":"36","author":"Saul","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"zoi251415r27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/ijgo.14797","article-title":"Pregnancy vaccination predictive factors and uptake profiles among Italian women: a cross-sectional survey study on a large population.","volume":"162","author":"Ferrari","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"zoi251415r12","unstructured":"Piano Nazionale Prevenzione Vaccinale 2017-2019 [National Plan for Vaccine Prevention 2017-19]. Ministero della Salute. Accessed December 12, 2024. https:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_2571_allegato.pdf"},{"key":"zoi251415r17","unstructured":"Linee guida per la classificazione e conduzione degli studi osservazionali sui farmaci. Agenzia Italiana Del Farmaco. Accessed December 11, 2024. https:\/\/www.aifa.gov.it\/documents\/20142\/0\/DETERMINAZ_AIFA_20_Marzo_2008_ST_OSS.pdf"},{"key":"zoi251415r28","unstructured":"National reports on medicines use in Italy year 2019. Italian Medicines Agency. Accessed December 13, 2024. https:\/\/www.aifa.gov.it\/documents\/20142\/241052\/OsMed_2019_Eng.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2843534\/morabito_2026_oi_251415_1767025234.26717.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:00:47Z","timestamp":1767888047000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2843534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.53179","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]}}}